NOTCH1 and diabetic kidney disease: In addition, EGCG treatment can significantly reduce the levels of Notch1 and TGF-βRII in HEK293 cells stimulated by high glucose, further supporting the potential of EGCG in the treatment of diabetic nephropathy.